US pharmaceutical giant Pfizer has announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world’s least-wealthy countries.
Pfizer will allow generic manufacturers to supply its promising Paxlovid pill to 95 low-and middle-income nations covering about 53% of the world’s population, the company said in a statement on Tuesday.
Under the licensing agreement deal struck with the global Medicines Patent Pool (MPP), Pfizer — which also produces one of the most widely used Covid vaccines with German lab BioNTech — will not receive royalties from the manufacturers, making the treatment cheaper.
The agreement is subject to the oral antiviral medication passing ongoing trials and regulatory approval.
Interim data
Read more on theguardian.com